Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 35 member E1 (SLC35E1) is a hydrophobic membrane protein belonging to the SLC35 subfamily of the SLC transporter superfamily[2]. The SLC35 family primarily comprises nucleotide sugar transporters that mediate the transport of nucleotide sugars and adenosine 3'-phospho 5'-phosphosulfate from the cytosol to the endoplasmic reticulum and Golgi apparatus, supporting proper glycosylation and sulfation of proteins, lipids, and proteoglycans[2]. Unlike well-characterized SLC35 members, the exact substrate and transport function for SLC35E1 remain unidentified; however, it is highly conserved, and mutations in key substrate-binding residues (e.g., lysine 142) impair its function[2]. Functionally, SLC35E1 has been shown to play a role in nuclear egress of virions during HSV-1 infection, meaning it facilitates the release of viral particles from the infected cell nucleus[2]. While related families are validated drug targets, and SLC proteins comprise ~20% of all membrane proteins, there are no drugs or biomarker applications specific to SLC35E1 at this time[2][1]. SLC35E1 is therefore best classified as a potential transporter and an accessory viral effector protein, with growing interest in its role in viral infection biology and possible involvement in glycosylation pathways, but with limited data on its therapeutic targeting, endogenous substrates, or disease implications outside of viral infection[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member E1 (SLC35E1).